27.06.2025 Notice of Consolidation

Notice of Delisting - 13.10.2025

Our ETPs

White Label

Company

Trading Hub

Income
How to Invest
  • Leverage & Inverse ETPs
All SnL ETPs
  • Commodities
All Commodities ETPs
  • Income ETPs
Tesla Options ETP
NVIDIA Options ETP
Gold+ Yield ETP
To IncomeShares

All ETPs

Discover 150+ Products

All ETPs
  • Market Insights
See All Insights
  • Education
See All Education
  • Instruments
  • White Label
About White Label
  • About
  • Why Us
  • FAQs
ISIN:
XS2779861249
COPY

5x Long Magnificent 7

The Leverage Shares 5x Long Magnificent 7 ETP seeks to provide 5x leveraged exposure to the daily return of the Solactive Magnificent 7 Index, minus fees and the costs of maintaining constant leverage in the Index components. The Index equally weights and tracks the performance of seven mega cap US listed companies: Alphabet, Amazon, Apple, Meta, Microsoft, NVIDIA and Tesla.

Capital at risk. For professional investors only.

Top Holdings: 

AlphabetAppleMicrosoftTeslaAmazonMetaNVIDIA

Explore more leverage factors:

–

Explore more leverage factors:

– –
How to Invest

NAV as of 

–

-

52 WK:

–

–

–

1 Day NAV Change

-

as of 

–

NAV Total Return

YTD:

-

as of 

–

AUM

-

as of 

–

Why 5x Long Magnificent 7?

Precision

Pure exposure to the “Magnificent 7” stocks.

Leveraged Returns

Get five times (5x) leveraged exposure through your brokerage account – no margin or CFD account needed.

Focused on Innovation

With a single trade, gain equal-weighted access to some of the most influential companies in the tech sector.

Performance

Data as of 

–
-
-
-
%
1M
3M
1Y
ALL
1M
3M
1Y
ALL

Summary

1D

-

1M

-

3M

-

YTD Return

-

1Y

-

ALL (Annualized)

-

ALL (Cumulative)

-

Volatility

Annualized Vol

-

52 Week

52 Week High

-

52 Week Low

-

Average Turnover

3M

-

ETP Documents

Notices

Related Articles

  • MARKET INSIGHTS

UnitedHealth Q3 Earnings Beat but Margins Squeezed

Despite stronger Q3 results and higher guidance, UnitedHealth faces profit margin strain.
Read more
Article Icon_ Q3 FY 2025 earnings UNH

UnitedHealth Q3 Earnings Beat but Margins Squeezed

Despite stronger Q3 results and higher guidance, UnitedHealth faces profit margin strain.
  • MARKET INSIGHTS
Read
Article Icon_ Q3 FY 2025 earnings UNH

UnitedHealth Q3 Earnings Beat but Margins Squeezed

Despite stronger Q3 results and higher guidance, UnitedHealth faces profit margin strain.
Read

Required Information

Welcome to Leverage Shares

INVESTOR TYPE:

LOCATION:

Please confirm the Terms and Conditions by clicking on “I agree”.

This website is for informational purposes only.

This website is accessible to retail investors in the EU for informational purposes only. Leverage Shares does not directly distribute to retail investors. Retail clients should not rely on any of the information provided and should seek independent financial advice.

Information contained in this website is intended only to provide general and preliminary information and does not constitute any legal or investment advice, an offer to sell or solicitation to buy any security, including shares of any Exchange Traded Products (“ETPs”).

An investment in the promoted ETPs may only be made based on the ETPs´ legal documentation and will be subject to terms and conditions contained therein.

The information provided on this site is not directed to any United States person or any person in the United States, any state thereof, or any of its territories or possessions. The ETPs shown on this website are not available for sale in the U.S. or to a U.S. person.

I acknowledge having my legal residence in the selected location.

Leverage Shares does not directly distribute to retail investors.

Please contact your financial adviser, or other investment professional, if you would like to discuss whether these products may be suitable for you.

This website is intended for U.S. residents.

The content on this website is for informational purposes only and is educational in nature.

The material contained on this website is not intended as a recommendation to buy, sell or hold any security or to adopt any investment strategy.

Please confirm the Terms and Conditions by clicking on “I agree”.

This website is for informational purposes only.

Information contained in this website is intended only to provide general and preliminary information to EU regulated firms such as Investment Intermediaries and Asset Managers. This information does not constitute an offer to sell or solicitation to buy any security, including shares of any Exchange Traded Products (“ETPs”).

An investment in the promoted ETPs may only be made based on the ETPs´ legal documentation and will be subject to terms and conditions contained therein.

The information provided on this site is not directed to any United States person or any person in the United States, any state thereof, or any of its territories or possessions. The ETPs shown on this website are not available for sale in the U.S. or to a U.S. person.

I acknowledge having my legal residence in the selected location.

Please confirm you have read and accept the Terms and Conditions by clicking on
“I agree”.

This website is for informational purposes only.

Information contained in this website is directed only at institutional investors and investment professionals intended only to provide general and preliminary information to such as FCA regulated firms such as Independent Financial Advisors (IFAs) and Wealth Managers. Nothing on this website is intended to information does not constitute an offer to sell or solicitation to buy any security, including shares of any Exchange Traded Products (“ETPs”).

An investment in the promoted ETPs may only be made based on the ETPs legal documentation and will be subject to terms and conditions contained therein.

The information provided on this site is not directed to any United States person or any person in the United States, any state thereof, or any of its territories or possessions. The ETPs shown on this website are not available for sale in the U.S. or to a U.S. person.

I confirm I am a professional investor and acknowledge having my legal residence in the selected location.

This website is intended for U.S. residents.

The content on this website is for informational purposes only and is educational in nature.

The material contained on this website is not intended as a recommendation to buy, sell or hold any security or to adopt any investment strategy.

x

Get the Newsletter

Never miss out on important announcements. Get premium content ahead of the crowd. Enjoy exclusive insights via the newsletter only.